Nimbus Therapeutics - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $67,369.25 +1.38%
Ethereum $2,052.01 +2.93%
BNB $616.97 +0.87%
Optimism $0.11 +5.12%
Arbitrum $0.09 +3.40%
Solana $83.99 +2.30%
Polygon $0.22 +2.77%
Cosmos $1.69 +2.39%
Avalanche $8.90 +2.50%

Bitcoin $67,369.25 +1.38%
Ethereum $2,052.01 +2.93%
BNB $616.97 +0.87%
Optimism $0.11 +5.12%
Arbitrum $0.09 +3.40%
Solana $83.99 +2.30%
Polygon $0.22 +2.77%
Cosmos $1.69 +2.39%
Avalanche $8.90 +2.50%

Nimbus Therapeutics

company

Investors

Number of Lead Investors

Number of Investors

7

17

Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.

Investor Name	Lead Investor	Funding Round
Access Biotechnology	-	Series Unknown
Atlas Venture	-	Series Unknown
Bain Capital Life Sciences	-	Series Unknown
Bill Gates	-	Series Unknown
Biotechnology Value Fund	-	Series Unknown
Lightstone Ventures	-	Series Unknown
Pfizer Venture Investments	-	Series Unknown
RA Capital Management	-	Series Unknown
SR One	-	Series Unknown
SV Health Investors	-	Series Unknown
Commodore Capital	-	Series Unknown
Logos Capital	-	Series Unknown
Surveyor Capital	-	Series Unknown
BVF Partners	-	Series Unknown
Lilly Ventures	-	Series C
Schrödinger	-	Series C
Richard Friesner	-	Seed